Hepion Pharmaceuticals Inc (HEPA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | HEPA | AMGN | VRTX | REGN | BMY |
| Company | Hepion Pharmaceuticals Inc | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 1.3700 | 276.11 | 396.20 | 892.11 | 44.40 |
| High | 1.4100 | 276.12 | 396.69 | 896.85 | 44.76 |
| Low | 1.3301 | 272.35 | 392.50 | 885.01 | 43.97 |
| Last | 1.4000 | 274.94 | 394.00 | 894.00 | 44.60 |
| Change | +0.0300 | -1.44 | -2.20 | +1.52 | -0.04 |
| % Change | +2.19% | -0.52% | -0.56% | +0.17% | -0.09% |
| Volume | 5,996 | 717,647 | 459,574 | 244,800 | 7,014,604 |
| 20-Day Average Volume | 54,023 | 2,120,267 | 908,383 | 446,605 | 13,377,471 |
| Previous Close | 1.3700 | 276.38 | 396.20 | 892.48 | 44.64 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.9771 | 269.57 | 399.30 | 911.58 | 48.64 |
| 20-Day Raw Stochastic | 10.71% | 85.97% | 12.49% | 19.66% | 6.80% |
| 20-Day Relative Strength | 35.27% | 50.21% | 40.06% | 37.42% | 28.49% |
| Weighted Alpha | -87.72 | +12.98 | +11.57 | +15.17 | -35.49 |
| Today's Opinion | 100% Sell | 40% Sell | 24% Sell | 8% Buy | 88% Sell |
| Previous Opinion | 100% Sell | 24% Sell | 8% Sell | 8% Buy | 88% Sell |
| Last Month's Opinion | 48% Sell | 24% Buy | 56% Buy | 96% Buy | 8% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -6.04% since 04/23/24 | +0.38% since 04/23/24 | -2.69% since 04/23/24 | -1.65% since 04/23/24 | -9.01% since 04/23/24 |
| Low | 1.2700 on 04/26/24 | 265.72 on 04/26/24 | 392.50 on 04/30/24 | 875.22 on 04/26/24 | 43.97 on 04/30/24 |
| High | 1.5400 on 04/24/24 | 276.86 on 04/29/24 | 406.83 on 04/24/24 | 915.70 on 04/24/24 | 49.04 on 04/24/24 |
| 1-Month | |||||
| %Chg | -43.78% since 03/28/24 | -3.42% since 03/28/24 | -5.74% since 03/28/24 | -7.29% since 03/28/24 | -17.80% since 03/28/24 |
| Low | 1.2200 on 04/22/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.97 on 04/30/24 |
| High | 2.8999 on 04/04/24 | 283.91 on 04/02/24 | 421.45 on 04/01/24 | 970.20 on 04/01/24 | 54.23 on 04/01/24 |
| 3-Month | |||||
| %Chg | -21.91% since 01/30/24 | -12.72% since 01/30/24 | -11.68% since 01/30/24 | -7.02% since 01/30/24 | -9.75% since 01/30/24 |
| Low | 1.2200 on 04/22/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.97 on 04/30/24 |
| High | 3.4899 on 02/16/24 | 329.72 on 02/05/24 | 444.07 on 01/31/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| 6-Month | |||||
| %Chg | -70.71% since 10/30/23 | +4.33% since 10/30/23 | +10.23% since 10/30/23 | +14.74% since 10/30/23 | -13.02% since 10/30/23 |
| Low | 1.2200 on 04/22/24 | 249.70 on 10/31/23 | 341.90 on 11/16/23 | 772.84 on 10/31/23 | 43.97 on 04/30/24 |
| High | 4.8398 on 10/31/23 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 7,497 | 148,243,600 | 102,401,456 | 97,960,392 | 90,489,744 |
| Shares Outstanding, K | 5,472 | 536,376 | 258,459 | 109,762 | 2,027,100 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 45,006,000,000 |
| Annual Net Income | -48,930,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 8,025,000,000 |
| Last Quarter Sales | 0 | 8,196,000,000 | 2,517,700,000 | 3,434,300,000 | 11,865,000,000 |
| Last Quarter Net Income | -11,060,000 | 767,000,000 | 968,800,000 | 1,159,600,000 | -11,911,000,000 |
| 60-Month Beta | 1.54 | 0.58 | 0.35 | 0.11 | 0.39 |
| Per-Share Information | |||||
| Most Recent Earnings | -2.42 on 04/16/24 | 4.71 on 02/06/24 | 4.20 on 02/05/24 | 11.86 on 02/02/24 | -4.40 on 04/25/24 |
| Latest Earnings Date | 05/10/24 | 05/02/24 | 05/06/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | N/A | N/A | 0.600 on 04/04/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 04/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.48 | 29.57 | 23.50 | 42.71 |